An interventional study of CBT-I and CBT-I combined ACT in Insomnia, Anxiety and Youth, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 15 Years to 24 Years. Per ClinicalTrials.gov, last updated 2025-07-10.
Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong — 14 open to participants now, 14 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Chinese University of Hong Kong.
Among the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong, this one is the 19th largest by planned enrollment, is one of 4 that started in 2023, is one of 24 with no phase, reaches primary completion later than 1 of the 13 other live ones, and was the 14th registered.
2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →14 of the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:
Chinese University of Hong Kong · Sites in Hong Kong
Ages 18–65
Chinese University of Hong Kong · Sites in Hong Kong
Ages 6–12
Chinese University of Hong Kong · Sites in Hong Kong
Ages 12–18
Chinese University of Hong Kong · Sites in Hong Kong
Ages 18–70 · Healthy volunteers
Chinese University of Hong Kong · Sites in Hong Kong
Ages 15–24 · Healthy volunteers
By country, each count listing its studies:
Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.
This study: 15 Years to 24 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 4 started in 2023.
This study's planned enrollment of 50 is below the median of 68 across 2,363 interventional studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 80 across the 25 interventional studies. Of the 5 that completed or were terminated, 1 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
Chinese University of Hong Kong is the lead sponsor of 1,458 studies on the registry; 478 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
3 of the studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07323069Chinese University of Hong KongA Nurse-led Multicomponent Interventional Protocol to Improve Sleep Quality in Paediatric Oncology Patients | 2027-01 |
| NCT06511011Chinese University of Hong KongChinese Medicine in Treating Insomnia | 2027-05 |
| NCT07770516Chinese University of Hong KongCognitive Behavioral Therapy for Insomnia as an Adjunct to Time-restricted Eating on Weight Loss in Adults With Overweight or Obesity and Chronic Insomnia | 2027-06-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Insomnia in adolescents and youth is a long-standing public health concern due to its high prevalence and association with various physical and mental health problems. Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. CBT for insomnia (CBT-I) has been shown to be effective in improving sleep complaints and short-term improvement in mood while previous systematic reviews of interventional studies have demonstrated the effectiveness of acceptance and commitment therapy (ACT) interventions in treating insomnia, both as a primary condition and with other physical and/or mental health comorbidities. This study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth.
Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. Moreover, approximately three-quarters of anxious youth also report sleep-related problems. Literature reviews have investigated the relationship and the shared underlying mechanisms between sleep and anxiety. Anxiety sensitivity and pre-sleep arousal have been found to play a critical role in difficulty initiating sleep, which is the most common insomnia symptoms in adolescent population, partially due their natural delay of circadian rhythm. The findings suggest shared neurological and cognitive features that may account for dysregulation of both sleep and affect. Management targeting both sleep and anxiety is recommended due to potentially higher treatment efficacy and cost-effectiveness.
Accumulating evidence supports the effectiveness of cognitive-behavioural therapy for insomnia (CBT-I) and acceptance and commitment therapy (ACT) for addressing sleep and mood problems in adolescents. However, Only a few studies have directly compared the effectiveness of CBT-I and ACT. Past studies have shown that both CBT-I and ACT were effective in treating insomnia in adults.
This current study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth. The primary hypothesis is that subjects in CBT-I combined ACT will have fewer anxiety symptoms as compared to CBT-I at post-intervention and 3-month follow-up.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Youth who meet the following criteria would be eligible for taking part in this trial:
i. Chinese youth aged 15-24 years old, ii. Presence of insomnia problems as defined by insomnia severity index (ISI) using cut-off of 9, which has been locally validated cut off for detecting clinical insomnia), iii. Presence of anxiety features as defined by General Anxiety Disorder-7 (GAD-7) using cut-off of 10 for detecting clinical anxiety, iv. Ability to listen, speak, and read Chinese and Cantonese, and v. Written of participation into the study is given by youth and his/her parent's if under 18 years old; In addition, individual assent will also be obtained for subjects under age 18 years old vi. Possession of smartphone
Exclusion Criteria:
A youth would be excluded from the study if meeting one or more of the following criteria:
i. A clinical diagnosis of psychosis, schizophrenia, bipolar disorders, or intellectual disability ii. Having a diagnosed sleep disorder (e.g. delayed sleep phase and narcolepsy) that may potentially contribute to the disruption of sleep quantity and quality as determined by validated Diagnostic Interview for Sleep Patterns and Disorders (DISP) iii. Having a suicidality (presence of suicidal ideation with a plan or an attempt) as assessed by The Structured Clinical Interview (SCID) iv. Currently receiving psychological treatment and/or pharmacological treatment for insomnia or anxiety disorder.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A total of 6 sessions of face-to-face group CBT-I therapy will be provided. Each session will last 90-120 mins, with each group 8-10 subjects.
Behavioral: CBT-I
A total of 6 sessions of face-to-face group CBT-I+ACT therapy will be provided. Each session will last 90-120 mins, with each group 8-10 subjects.
Behavioral: CBT-I combined ACT
The CBT-I intervention will cover sleep education, stimulus control, sleep restriction, cognitive therapy and relaxation training.
In addition to the standard CBT-I components, mindfulness, thought diary, and other ACT components will be taught in the group.
Severity of anxiety symptoms and severity
General Anxiety Disorder-7 (GAD-7) will be used to assess anxiety symptoms and severity.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Severity of anxiety symptoms
Hospital Anxiety and Depression Scale (HADS) will be used to assess anxiety symptoms.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Clinician-rated severity of anxiety symptoms
Hamilton Anxiety Rating Scale (HAM-A) will be used to assess anxiety symptoms.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Severity of insomnia symptoms
Insomnia Severity Index (ISI) will be used to measure the severity of insomnia symptoms.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Sleep-wake pattern
Youths will be asked to keep a sleep diary to chart their daily sleep-wake pattern including sleep duration, wakeup time, bedtime and sleep latency
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Daytime sleepiness
Pediatric Daytime Sleepiness Scale (PDSS) will be used to assess adolescents' daytime sleepiness.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Anxiety trait
The State-Trait Anxiety Inventory (STAI) will be used to measure anxiety trait
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Severity of depressive symptoms
Patient Health Questionnaire 9-item (PHQ-9) will be used to measure the severity of depressive symptoms.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Faulty sleep-related beliefs and cognitions
Dysfunctional Beliefs and Attitudes about Sleep Scale-16-item (DBAS-16) will be used to measure faulty sleep-related beliefs and cognitions, which are cognitive aspects typically involved in the maintenance of insomnia.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Frequency of an individual practice sleep hygiene
Sleep Hygiene Practice Scale (SHPS) will be used to measure the frequency of an individual practice sleep hygiene.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Psychological flexibility and experiential avoidance
Acceptance and Action Questionnaire-II (AAQ-II) is related to the underlying ACT theory to measure psychological flexibility and experiential avoidance.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Individual's state of arousal
Pre-Sleep Arousal Scale (PSAS) will be used to measure individual's state of arousal as one falls asleep.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Tendency to ruminate
The Ruminative Responses Scale - short version (RRS-10) is a 10-item scale on a 4-likert scale. It measures the tendency to ruminate.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Major life events and hassles
The Adolescent Stress Index (ASI), which was developed using a Hong Kong student sample, will be used to measure major life events and hassles
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Global cognitive appraisal of one's life satisfaction
The Satisfaction With Life Scale (SWLS): SWLS is a 5-item scale on a 7-Likert scale. It measures the global cognitive appraisal of one's life satisfaction.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Subjective well-being in the previous week
The International Positive and Negative Affect Schedule Short Form (IPANAS-SF) will be used to capture the subjective well-being in the previous week. It has 9 items on a 5-Likert scale with previous study demonstrating satisfactory internal consistency reliability and reasonable nomological validity in Chinese youth.
Time frame: Baseline, Postintervention (6 weeks), and 3-month follow up
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2023 (actual). Primary completion is estimated for Dec 2025, 24 months after the start.
Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 24 months is above that.
Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleep Initiation and Maintenance Disorders →
Chinese University of Hong Kong →